Thyroid – Differentiated and Anaplastic Carcinoma

[1]  Mousumi Banerjee,et al.  The role of pancreatic stellate cells in pancreatic disorders , 2016 .

[2]  A. Miyauchi,et al.  Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy. , 2011, Thyroid : official journal of the American Thyroid Association.

[3]  Ming-Hsun Wu,et al.  Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer , 2015, Head & neck.

[4]  H. Yamashita,et al.  Extracapsular invasion of lymph node metastasis , 1999, Cancer.

[5]  F. Rubino,et al.  Prognostic factors in differentiated thyroid carcinoma: A multivariate analysis of 234 consecutive patients , 1998, Journal of surgical oncology.

[6]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[7]  A. Miyauchi,et al.  Prognostic Significance of Extrathyroid Extension of Papillary Thyroid Carcinoma: Massive but Not Minimal Extension Affects the Relapse-free Survival , 2006, World Journal of Surgery.

[8]  Peter M. Sadow,et al.  Malignant struma ovarii , 2008, Nature Clinical Practice Endocrinology &Metabolism.

[9]  Amy Y. Chen,et al.  Prognostic indicators in well‐differentiated thyroid carcinoma when controlling for stage and treatment , 2015, The Laryngoscope.

[10]  Su-jin Kim,et al.  Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer , 2015, PloS one.

[11]  J. Shah,et al.  Differentiated carcinoma of the thyroid with extrathyroidal extension. , 1995, American journal of surgery.

[12]  J. Shah,et al.  The impact of nodal status on outcome in older patients with papillary thyroid cancer. , 2014, Surgery.

[13]  C. Carrasco,et al.  Management of Well-Differentiated Thyroglossal Remnant Thyroid Carcinoma: Time To Close the Debate? Report of Five New Cases and Proposal of a Definitive Algorithm for Treatment , 2006, Annals of Surgical Oncology.

[14]  David F. Schneider,et al.  Impact of Lymph Node Ratio on Survival in Papillary Thyroid Cancer , 2013, Annals of surgical oncology.

[15]  H. Moon,et al.  Minimal Extrathyroidal Extension in Patients with Papillary Thyroid Microcarcinoma: Is It a Real Prognostic Factor? , 2011, Annals of Surgical Oncology.

[16]  N. Wada,et al.  Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension. , 2007, The Journal of clinical endocrinology and metabolism.

[17]  Susan Halabi,et al.  American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine , 2016, CA: a cancer journal for clinicians.

[18]  A. Ho,et al.  Novel Approaches to Thyroid Cancer Treatment and Response Assessment. , 2016, Seminars in nuclear medicine.

[19]  H. Yamashita,et al.  Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma , 1997, Cancer.

[20]  J. Shah,et al.  The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer. , 2011, Surgery.

[21]  Ryan K. Orosco,et al.  Analysis of age and disease status as predictors of thyroid cancer-specific mortality using the Surveillance, Epidemiology, and End Results database. , 2015, Thyroid : official journal of the American Thyroid Association.

[22]  Z. Baloch,et al.  Pathology of Thyroglossal Duct: an Institutional Experience , 2015, Endocrine Pathology.

[23]  E. Kebebew,et al.  Anaplastic thyroid carcinoma , 2005, Cancer.

[24]  Samuel L. Oyer,et al.  Comparison of Survival Rates Between Papillary and Follicular Thyroid Carcinomas Among 36,725 Patients , 2014, The Annals of otology, rhinology, and laryngology.

[25]  M. Hirokawa,et al.  Prognostic Impact of Extrathyroid Extension and Clinical Lymph Node Metastasis in Papillary Thyroid Carcinoma Depend on Carcinoma Size , 2010, World Journal of Surgery.

[26]  Y. Nikiforov,et al.  American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. , 2012, Thyroid : official journal of the American Thyroid Association.

[27]  David D. Smith,et al.  The Implication of Lymph Node Metastasis on Survival in Patients with Well-Differentiated Thyroid Cancer , 2005, The American surgeon.

[28]  I. Fleming,et al.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.

[29]  K. Pathak,et al.  The age factor in survival of a population cohort of well-differentiated thyroid cancer , 2013, Endocrine connections.

[30]  A. Miyauchi,et al.  Ultrasonographically and Anatomopathologically Detectable Node Metastases in the Lateral Compartment as Indicators of Worse Relapse-free Survival in Patients with Papillary Thyroid Carcinoma , 2005, World Journal of Surgery.

[31]  A. Miyauchi,et al.  Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. , 2009, Endocrine journal.

[32]  VALERIE A. SMITH,et al.  Cervical lymph node metastasis and papillary thyroid carcinoma: Does the compartment involved affect survival? Experience from the SEER database , 2012, Journal of surgical oncology.

[33]  E. Odell,et al.  Mucoepidermoid carcinoma in a thyroglossal duct remnant , 2015, International journal of surgery case reports.

[34]  K. Pathak,et al.  Identifying the most appropriate age threshold for TNM stage grouping of well-differentiated thyroid cancer. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  N. Socci,et al.  Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. , 2013, The Journal of clinical endocrinology and metabolism.

[36]  Kwang Hee Kim,et al.  Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma. , 2013, International journal of surgery.

[37]  R. Tuttle,et al.  Update on differentiated thyroid cancer staging. , 2014, Endocrinology and metabolism clinics of North America.

[38]  E. Baudin,et al.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. , 2005, The Journal of clinical endocrinology and metabolism.

[39]  D. Flieder,et al.  Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. , 2013, Thyroid : official journal of the American Thyroid Association.

[40]  A. Miyauchi,et al.  Establishment of an Intraoperative Staging System (iStage) by Improving UICC TNM Classification System for Papillary Thyroid Carcinoma , 2010, World Journal of Surgery.

[41]  Samuel L. Oyer,et al.  Reevaluating the Prognostic Significance of Age in Differentiated Thyroid Cancer , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[42]  P. Walfish,et al.  Prospective management of nodal metastases in differentiated thyroid cancer. , 1991, American journal of surgery.

[43]  S. Mandel,et al.  The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. , 2012, Thyroid : official journal of the American Thyroid Association.

[44]  J. Thariat,et al.  Lethal, malignant, metastatic struma ovarii. , 2010, Thyroid : official journal of the American Thyroid Association.

[45]  M. van Glabbeke,et al.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. , 1979, European journal of cancer.

[46]  H. Mazeh,et al.  Thyroglossal duct remnant carcinoma: beyond the Sistrunk procedure. , 2014, Surgical oncology.

[47]  R. Kloos,et al.  Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[48]  E. Bergstralh,et al.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.

[49]  R. Kloos,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society CLINICAL REVIEW 128 Current Approaches to Primary Therapy for Papillary , 2022 .

[50]  L. Gordini,et al.  Tall cell carcinoma arising in a thyroglossal duct cyst: A case report , 2015, Annals of medicine and surgery.

[51]  Ricardo Rossi,et al.  An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. , 2009, The Journal of clinical endocrinology and metabolism.

[52]  E. Pribitkin,et al.  Is above age 45 appropriate for upstaging well-differentiated papillary thyroid cancer? , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[53]  J. Shah,et al.  Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure. , 2015, Thyroid : official journal of the American Thyroid Association.

[54]  J. Shah,et al.  Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It? , 2015, Thyroid : official journal of the American Thyroid Association.

[55]  N. Wada,et al.  Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[56]  P. Baade,et al.  Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer , 2014, Endocrine.

[57]  T. Klonisch,et al.  Prognostic nomograms to predict oncological outcome of thyroid cancers. , 2013, The Journal of clinical endocrinology and metabolism.

[58]  N. Bhattacharyya.  A Population-Based Analysis of Survival Factors in Differentiated and Medullary Thyroid Carcinoma , 2003, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[59]  J. Jonklaas,et al.  The impact of age and gender on papillary thyroid cancer survival. , 2012, The Journal of clinical endocrinology and metabolism.

[60]  S. Roman,et al.  Malignant struma ovarii: a population-level analysis of a large series of 68 patients. , 2015, Thyroid : official journal of the American Thyroid Association.

[61]  A. Miyauchi,et al.  Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. , 2007, Thyroid : official journal of the American Thyroid Association.

[62]  B. Lang,et al.  Staging Systems for Papillary Thyroid Carcinoma: A Study of 2 Tertiary Referral Centers , 2007, Annals of surgery.

[63]  Y. Nikiforov,et al.  Erratum: American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer (Thyroid (2012) 22:11 (1104-1139)) , 2012 .

[64]  B. Cha,et al.  Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules. , 2007, Thyroid : official journal of the American Thyroid Association.

[65]  H. AlpertErin,et al.  Size distribution of metastatic lymph nodes with extranodal extension in patients with papillary thyroid cancer: a pilot study. , 2015 .

[66]  D. Chang,et al.  A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry. , 2012, Surgery.

[67]  R. Ghossein.  Encapsulated Malignant Follicular Cell-Derived Thyroid Tumors , 2010, Endocrine pathology.

[68]  A. Stojadinovic,et al.  Impact of degree of extrathyroidal extension of disease on papillary thyroid cancer outcome. , 2014, Thyroid : official journal of the American Thyroid Association.

[69]  I. Hay.  Papillary thyroid carcinoma. , 1990, Endocrinology and metabolism clinics of North America.

[70]  M. Rivera,et al.  Histologically Bland “Extremely Well Differentiated” Thyroid Carcinomas Arising in Struma Ovarii can Recur and Metastasize , 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[71]  Louise Davies,et al.  Current thyroid cancer trends in the United States. , 2014, JAMA otolaryngology-- head & neck surgery.

[72]  V. Zaydfudim,et al.  The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. , 2008, Surgery.

[73]  R. Ferris,et al.  American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. , 2012, Thyroid : official journal of the American Thyroid Association.

[74]  H. Min,et al.  Follicular Proliferative Lesion Arising in Struma Ovarii , 2015, Journal of pathology and translational medicine.

[75]  D. Steward,et al.  Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance. , 2015, Thyroid : official journal of the American Thyroid Association.

[76]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[77]  J. Shah,et al.  Impact of lymph node metastasis in differentiated carcinoma of the thyroid: A matched‐pair analysis , 1996, Head & neck.

[78]  J. Percodani,et al.  Lymph node management in clinically node-negative patients with papillary thyroid carcinoma. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[79]  R. Ghossein.  Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin. , 2009, Archives of pathology & laboratory medicine.

[80]  A. Buck,et al.  Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. , 2013, The Journal of clinical endocrinology and metabolism.

[81]  J. Shah,et al.  Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer , 2016, Annals of Surgical Oncology.

[82]  S. Roman,et al.  Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  A. Miyauchi,et al.  Risk Factors for Recurrence to the Lymph Node in Papillary Thyroid Carcinoma Patients without Preoperatively Detectable Lateral Node Metastasis: Validity of Prophylactic Modified Radical Neck Dissection , 2007, World Journal of Surgery.

[84]  A. Félix,et al.  Papillary carcinoma arising in struma ovarii versus ovarian metastasis from primary thyroid carcinoma: a case report and review of the literature. , 2013, Journal of radiology case reports.

[85]  Koichi Ito,et al.  Lymph Node Metastasis From 259 Papillary Thyroid Microcarcinomas: Frequency, Pattern of Occurrence and Recurrence, and Optimal Strategy for Neck Dissection , 2003, Annals of surgery.

[86]  M. WenigBruce,et al.  Extrathyroidal extension predicts extranodal extension in patients with positive lymph nodes: an important association that may affect clinical management. , 2014 .

[87]  N. Sakamoto,et al.  Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  J. Roh,et al.  Central Cervical Nodal Metastasis from Papillary Thyroid Microcarcinoma: Pattern and Factors Predictive of Nodal Metastasis , 2008, Annals of Surgical Oncology.

[89]  R. Ghossein,et al.  Encapsulated Thyroid Carcinoma of Follicular Cell Origin , 2015, Endocrine Pathology.

[90]  P. Schneider,et al.  An Evaluation of Lymph Node Yield and Lymph Node Ratio in Well-Differentiated Thyroid Carcinoma , 2010, The American surgeon.

[91]  S. Asa,et al.  Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation , 2011, Modern Pathology.

[92]  Mayuri Singh,et al.  A Case of Papillary Thyroid Carcinoma in Struma Ovarii and Review of the Literature , 2010, Pathology research international.

[93]  S. Yamashita,et al.  Surgical management of primary thyroid carcinoma arising in thyroglossal duct cyst: an experience of a single institution in Serbia. , 2012, Endocrine journal.

[94]  R. Kurman,et al.  WHO classification of tumours of female reproductive organs , 2014 .

[95]  Tae Yong Kim,et al.  Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas , 2015, Annals of Surgical Oncology.

[96]  J. Shah,et al.  Management of well‐differentiated thyroid carcinoma presenting within a thyroglossal duct cyst , 2002, Journal of surgical oncology.

[97]  T. Fahey,et al.  Extrathyroidal extension is not all equal: Implications of macroscopic versus microscopic extent in papillary thyroid carcinoma. , 2008, Surgery.

[98]  J. Ricarte-Filho,et al.  Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. , 2011, Thyroid : official journal of the American Thyroid Association.

[99]  Tae Yong Kim,et al.  Papillary thyroid carcinoma arising from a thyroglossal duct cyst: a single institution experience. , 2013, Endocrine journal.

[100]  J. Shah,et al.  Thyroid carcinoma, version 2.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[101]  H. Dralle,et al.  Determinative Factors of Biochemical Cure after Primary and Reoperative Surgery for Sporadic Medullary Thyroid Carcinoma , 1998, World Journal of Surgery.

[102]  R. Bentley,et al.  Malignant Struma Ovarii: An Analysis of 88 Cases, Including 27 With Extraovarian Spread , 2009, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.